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Abstract
Background: Patients with an advanced incurable disease are often hospitalised for some time during the last
phase of life. Care in hospitals is generally focussed at curing disease and prolonging life and may therefore not in
all cases adequately address the needs of such patients. We present the COMPASS study, a study on the effects and
costs of consultation teams for palliative care in hospitals.
This observational study aims to investigate the use, effects and costs of PCT consultation services for hospitalized
patients with incurable cancer in the Netherlands.
Methods/design: The study consists of 3 parts:
1. A questionnaire, interviews and a focus group discussion to investigate the characteristics of PCT consultation in
12 hospitals. PCTs will register their activities to calculate the costs of PCT consultation.
2. Cancer patients for whom the attending physician would not be surprised that they would die within 12 month
will be included in a medical file search in three hospitals. Medical records will be investigated to compare care,
treatment and hospital costs between patients with and patients without PCT consultation.
3. In the other nine hospitals, we will perform a longitudinal study, and compare quality of life between 100
patients for whom a PCT was consulted with 200 patients without PCT consultation. Propensity score matching will
be used to adjust for differences between both patient groups. Patients will be followed for three months after
inclusion. Quality of life will be assessed with the Palliative Outcome Scale, the EuroQol-5d and the EORTC-QLQ-C15
PAL. Satisfaction with care in the hospital is measured with the IN-PATSAT32. The cost impact of PCT consultation
will also be explored.
Discussion: This is the first multicenter study on PCT consultation in the Netherlands. The study will give valuable
insight in the process, effects and costs of PCT consultation in hospitals. It is anticipated that PCT consultation has a
positive effect on patients’ quality of life and satisfaction with care and will lead to less hospital care costs.
Keywords: Palliative care, Palliative medicine, Referral and consultation, Quality of life, Cancer, Costs and costs
analysis, Patient satisfaction, Hospitals, Observational study, Longitudinal study
Background
Patients with an advanced incurable disease often spend
some time in hospital during the last months of life [1].
When death is approaching for such patients, the goals
of care need to be realigned. However, burdensome
medical interventions are often prolonged until the end
of life, without any beneficial effect [2–5]. As a result,
end-of-life care in hospitals tends to involve high costs
while failing to address patients’ needs and to provide
them with a dignified death.
Palliative care is aimed at acknowledging patients’
impending death and at reconsidering goals of care
[6]. It is an approach that improves the quality of life
and their families facing the problems associated with
life-threatening illness, through the prevention and re-
lief of suffering by means of early identification and
impeccable assessment and treatment of pain and
other problems, physical, psychosocial and spiritual
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[7]. Palliative care is not only provided at the end of
life, but also in earlier stages, sometimes alongside
disease-directed interventions that are aimed at curing
disease or prolonging life [8]. Basic palliative care,
such as basic symptom management and supporting
patients to align their treatment choices with their
values and goals, should be delivered by any health
professional attending patients in the last phase of
life. Other, more complex forms of care, such as
managing refractory symptoms or negotiating a diffi-
cult family meeting, may require involvement of spe-
cialized palliative care professionals [8].
The effects of palliative care team consultation
Several studies have shown that the deployment of spe-
cialized palliative care teams (PCTs) in hospitals is associ-
ated with better outcomes for patients with advanced
disease [9]. Their involvement was found to improve pa-
tients’ quality of life [10–12], their satisfaction with care
[12, 13] and communication about goals of care, resulting
in less diagnostic testing and less use of inappropriate
technology and intensive care [14]. In a recent study
Temel et al. found that patients with lung cancer receiving
early palliative care had a better quality of life, received
less aggressive treatment and had a longer survival com-
pared to patients receiving usual care without palliative
care involvement [15]. Consultation of palliative care ser-
vices for patients with advanced incurable disease may
also influence health care costs, through its focus on
assessing patients’ goals of care and providing treatments
that are concordant with these goals. Several studies have
demonstrated significant cost savings as a result of pallia-
tive care involvement [13, 14, 16–18]. The largest group
of patients who are referred to specialized palliative or
end-of-life care services consists of patients with incurable
cancer, in the Netherlands as well as in other countries
[19, 20]. However, the provision of palliative care to pa-
tients with advanced cancer often remains suboptimal. In-
formational, emotional and physical needs are
frequently unmet among patients with incurable dis-
ease [21–24]. Studies show that PCT consultation is
only used for a minority of all patients with advanced
disease, which suggests that this service is used sub-
optimally [25]. This might be due to a lack of aware-
ness of the availability and potential contribution of
this service among regular health care professionals.
Furthermore, it is known that PCTs are often con-
sulted late in the disease trajectory [26]. There may
also be barriers to consultation, such as the lack of
referral criteria, and the view that the involvement of
palliative care is a signal that the primary health care
professionals have given up all hope for a patient
[27–29].
Palliative care team consultation in hospitals in the
Netherlands
The Netherlands has a nationwide system of palliative
care consultation services, that is predominantly used
by general practitioners for patients staying at home
[30–32]. More recently, hospitals have started estab-
lishing PCT consultation services. An inventory of the
Comprehensive Cancer Centre Netherlands in 2013
showed that at least 45 hospitals in the Netherlands,
out of a total of 92, were in different stages of imple-
menting such consultation services [33]. Most
hospital-based specialist PCTs can be consulted by
physicians or nurses working in the hospital. Upon
their involvement, PCTs typically provide a detailed
holistic assessment of the patients’ and family´s situ-
ation. They assess patients’ symptoms and their phys-
ical, emotional, social and spiritual problems,
prioritize these and propose a care plan to address
them. The extent to which PCTs provide care them-
selves or only advise the primary caregivers varies.
Most PCTs consist of professionals from different
specialties, such as oncologists, neurologists, anaesthe-
siologists, nurses, and psychosocial and spiritual care-
givers. The structure and activities of PCTs in
hospitals vary. Some PCTs are strongly embedded in
the hospital and supported by their hospital boards,
whereas others are not. Some teams are involved in
education within or outside the hospital.
Objectives
Evidence on the effects of PCT consultation in hospitals
on patient outcomes and health care costs mainly comes
from studies from the United States. It is unclear to
what extent these results can be generalized to other
countries with different health care systems and cultures,
such as the Netherlands. We will therefore perform an
observational study to investigate the use, effects and
costs of PCT consultation services for hospitalized pa-
tients with incurable cancer in the Netherlands. We will
1. assess the characteristics of PCT consultation
services in different hospitals,
2. study whether PCT consultation for patients with
incurable cancer has an effect on in-hospital medical
care,
3. explore whether PCT consultation for patients with
incurable cancer has beneficial effects on patients’
quality of life and satisfaction with care and
4. explore whether PCT consultation reduces costs of
care and might be a cost-effective intervention.
Methods
We will collect data in three substudies.
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Characteristics of PCT consultation in Dutch hospitals
We will use a structured questionnaire to study struc-
ture and process characteristics of PCT consultation ser-
vices in 12 hospitals in the Netherlands. All teams will
be asked to fill out this questionnaire, which contains
multiple choice and open questions regarding the disci-
plines that are represented in the PCT, the process of
consultation and the way the teams monitor and im-
prove the quality of their consultation. Further, all teams
will be invited to participate in group discussions or in-
dividual interviews to explore differences between teams
and PCT members’ experiences of barriers and facilita-
tors of a successful consultation service.
The effect of PCT consultation for patients with incurable
cancer on medical care
In three hospitals, care and treatment as provided to pa-
tients with advanced incurable cancer for whom a PCT
is consulted during their stay in the hospital will be
compared with care and treatment as provided to com-
parable patients without PCT consultation. Inclusion cri-
teria are that patients are 18 years or over and that the
attending physician answers “no” to the question
“Would you be surprised if this patient would die in the
next year?”. We will check the medical files of all eligible
patients to assess the use of diagnostic procedures,
medication, chemotherapy and other medical interven-
tions, and days spent in hospital, during 3 months after
inclusion. The attending physician will be asked to pro-
vide information on the patient’s diagnosis, performance
status, co morbidity and life expectancy, by filling out a
short questionnaire. For those patients for whom a PCT
is consulted, PCTs will be asked to fill out a question-
naire about the content of the consultation.
The use of medical care and the number of days spent
in hospital will be compared between patients with PCT
consultation and patients without PCT consultation,
while taking into account differences in patients’ medical
characteristics.
The effect of PCT consultation for patients with incurable
cancer on quality of life and the cost effectiveness of PCT
consultation
In 9 hospitals we will study the effect of PCT consult-
ation for in-hospital patients with incurable cancer on
quality of life. In order to get a good overview of differ-
ent types of hospitals, a university hospital, teaching and
general hospitals will be included. In order to include
sufficient comparable patients receiving usual care 3
hospitals without a PCT will be included.
Inclusion criteria are that patients are 18 years or over;
that the attending physician answers “no” to the ques-
tion “Would you be surprised if this patient would die in
the next year?”; and that the patient is expected to stay
in the hospital for at least 3 days. The latter criterium is
added to enable an informed consent procedure. Pa-
tients will be included upon arrival in the hospital. Eli-
gible patients will receive an information letter, and will
be informed and asked to participate by an attending
nurse. Patients who agree to participate will be followed
during three months, regardless of where they stay. The
attending physician will be asked to fill in a question-
naire to assess medical information such as diagnosis,
performance status, co morbidity and life expectancy.
Palliative care consultation teams are asked to fill a
questionnaire about the content of the consultation. Pa-
tients will be asked to fill out a number of subsequent
questionnaires. In these questionnaires, quality of life is
assessed with the EORTC QLQ-C15 PAL [34]. We will
also measure quality of life with the Palliative Outcome
Scale [35] and the EuroQol-5D [36] , because of the lack
of consensus on the most appropriate quality of life in-
strument for patients with incurable disease [37]. Sec-
ondary measures are symptom scores for pain,
dyspnoea and anxiety (EORTC QLQ-C15); patient sat-
isfaction with care, using the INPATSAT 32 question-
naire [38, 39]. Quality of life will be assessed
longitudinally at six moments in time: at day 4, 7, 14,
30, 60 and 90 after admission to the hospital; satisfac-
tion with care will be assessed at day 14 after
admission.
We aim to include 100 patients for whom a PCT was
consulted and compare them with at least 200 patients
receiving usual care. With such a sample size we will be
able to detect a difference in quality of life as measured
by the EORTC QLQ-C15 PAL at day 14 of 0.4 in stand-
ard deviation units (Cohen’s D = effect size) with alpha
of 0.05 (2-sided) and power of 90 %.
Data analysis
Due to the observational design of the study it is likely
that there is an imbalance of prognostic factors between
patients who are and patients who are not receiving
PCT consultation. As a consequence the estimated ef-
fects of PCT consultation can be biased. We will adjust
for imbalance in the statistical analysis by using propen-
sity scores [40–42].
We will develop a propensity score model to assess
the probability that a patient would have been offered
PCT consultation. Patient characteristics to be included
in this model are age, sex, marital status, primary diag-
nosis, reason for hospitalization (e.g. treatment of com-
plex symptoms, palliative chemotherapy, treatment of
complications), life expectancy, functional status, attend-
ing physician specialty, comorbidity, and hospital of
admission [14, 16]. The logit of the propensity score will
be used to match each patient receiving PCT consult-
ation with one or more usual care patients.
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Quality of life scores at different time points will be
compared between the PCT and care as usual groups
with repeated measurement analysis. A model will be fit-
ted that includes matched-pairs, time, treatment group,
the baseline score, and interaction between time and
treatment group.
Economic evaluation
The economic evaluation of PCT consultation in hospi-
tals will concern a period of three months after admit-
tance of patients to the hospital.
Data from substudy 2 will be used to perform a cost-
minimisation analysis including hospital costs. We will
distinguish intramural medical costs (inpatient days, pro-
fessional health caregivers’ activities, medical procedures).
Real medical costs will be calculated by multiplying the
volumes of health care use with the corresponding unit
prices. Costs for inpatient days in hospitals will be esti-
mated as real, basic costs per day using detailed hospital
administrative information. We will make a distinction be-
tween the costs in general hospitals and university hospi-
tals. The unit price of the PCTs will be determined with
the micro-costing method [43], which is based on a de-
tailed assessment of all resources used.
Data from substudy 3 will be used to perform an eco-
nomic evaluation from a health care perspective. We will
calculate total medical costs per patient, including intra-
mural and extramural medical costs (home care, nursing
home days, general practitioner activities). For the calcu-
lation of the intramural medical care costs and the unit
price of PCTs we use the same methodology as for the
cost-minimisation study. For the calculation of extra-
mural medical costs, we will use charges as published in
Dutch guidelines as a proxy of real costs [44]. The cost-
effectiveness of PCT consultation will be assessed by cal-
culating the incremental cost-effectiveness ratio (ICER),
defined as the difference in costs of PCT consultation
compared to usual care, divided by the average change
in patients’ quality of life . The primary effect measure
for the economic evaluation of PCT consultation is qual-
ity of life as measured by the EORTC QLQ-C15. Be-
cause of the short time horizon, costs and effects will
not be discounted.
Feasibility of recruitment
We expect to be able to include the needed number of
patients in a period of 18 months. The participating de-
partments will be asked to assign a nurse who is respon-
sible for checking the eligibility of all admitted patients.
This method proved to be successful in a previous study
[3]. Patients with incurable cancer have been found to
be at least as willing to participate in scientific research
as patients in other stages of disease [3, 45]. Whereas
our study is an observational study in which patients are
only asked to fill out a number of questionnaires, our
modest assumption of a 60 % participation rate seems
justified.
Ethical considerations
The research protocol was submitted to the Medical
Ethical Research Committee of the Erasmus Medical
Center who declared that there were no objections to
the performance of this study.
Substudy 1 is not related to patients but to caregivers.
Caregivers consented to participate in the group discus-
sions or individual interviews. For substudy 2, according
to national regulations, informed consent does not have
to be obtained, because data on medical care and deci-
sion making will be gathered locally and stored anonym-
ously in a database. For substudy 3, written informed
consent will be obtained from all participants.
Discussion
The objective of the COMPASS study is to assess the
process and outcomes of hospital palliative care consult-
ation in the Netherlands. The study has several potential
strengths, weaknesses, threats and opportunities that are
associated with the design of the study and with the spe-
cific population.
Strengths and weaknesses
To our knowledge this is the first study to assess the ef-
fects of hospital palliative care consultation in the
Netherlands. The number of participating hospitals [12]
and PCTs [9], representing academic, teaching and gen-
erals hospitals, is a strength of this study because in this
way we gain insight in different settings.Furthermore, we
will study PCT consultation in ‘real life’ and not in an
experimental setting. However, the observational design
of the COMPASS study can also be viewed as a weak-
ness. Randomized studies on the effects of health service
changes in palliative and end-of-life care are often not
possible, due to ethical and practical constraints. Firstly,
specialized palliative care services may not only have an
impact on individual patient care, but also on general at-
titudes of hospital caregivers towards care for patients in
the last stage of life, which would contaminate assess-
ments in the control groups. Secondly, several hospitals,
especially those that are at the forefront of developing
palliative care have already implemented PCT consult-
ation facilities for several years, which makes random-
ized evaluation of such facilities impossible. When
randomized trials are not feasible, as is the case in our
study, a well-designed observational study is an appro-
priate alternative [46]. Some previous studies on the ef-
fects and costs of specialized palliative care services
were observational and used novel statistical techniques,
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such as propensity scores, to define comparable patient
groups [22].
Threats and opportunities
The threats to the successful conduct of this study
relate mainly to the inclusion of patients. Nurses may
be reluctant to ask patients for informed consent as
participation in research may impose undue burden
on patients and caregivers [47]. However, studies have
found that many patients with advanced illnesses
actually appreciate to participate in research [47]. Fur-
thermore, it is known that PCTs are often consulted
relatively late in the disease trajectory [27, 48], which
means patients may not be able to participate by fill-
ing in questionnaires. Furthermore, some patients will
be lost to follow up, which is inherent to the study
population.
Implications
This study will provide insight in the process and
outcomes of PCT consultation in Dutch hospitals.
This knowledge is important for existing and new
PCTs. The outcomes can be used to optimize
hospital-based PCT consultation services for patients
with advanced illnesses.
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